Xu was named on Nature’s 10 in 2024 and the TIME100 Health 2025 list for pioneering a world-first CAR-T cell therapy for autoimmune diseases. His team developed a scalable approach using donor-derived engineered immune cells, achieving unprecedented remission in severe, treatment-resistant patients. His work offers a potentially curative, cost-effective strategy that could transform treatment for millions affected by autoimmune disorders worldwide.

(Photo: Nature Briefing)